% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bendella:283100,
author = {Bendella, Zeynep and Widmann, Catherine Nichols and
Kindler, Christine and Haase, Robert and Sauer, Malte and
Heneka, Michael and Radbruch, Alexander and Schmeel,
Frederic Carsten},
title = {{L}ongitudinal {M}onitoring of {B}rain {V}olume {C}hanges
{A}fter {COVID}-19 {I}nfection {U}sing {A}rtificial
{I}ntelligence-{B}ased {MRI} {V}olumetry.},
journal = {Diagnostics},
volume = {15},
number = {24},
issn = {2075-4418},
address = {Basel},
publisher = {MDPI},
reportid = {DZNE-2025-01507},
pages = {3244},
year = {2025},
abstract = {Background/Objectives: SARS-CoV-2 infection has been linked
to long-term neurological sequelae and structural brain
alterations. Previous analyses, including baseline results
from the COVIMMUNE-Clin study, showed brain volume
reductions in COVID-19 patients. Longitudinal data on
progression are scarce. This study examined brain volume
changes 12 months after baseline MRI in individuals who have
recovered from mild or severe COVID-19 compared with
controls. Methods: In this IRB-approved cohort study, 112
out of 172 recruited age- and sex-matched participants (38
controls, 36 mild/asymptomatic 38 severe COVID-19) underwent
standardized brain MRI 12 months after baseline. Volumetric
analysis was performed using AI-based software (mdbrain).
Regional volumes were compared between groups with respect
to absolute and normalized values. Multivariate regression
controlled for demographics. Results: After 12 months, a
significant decline in right hippocampal volume was observed
across all groups, most pronounced in severe COVID-19 (SEV:
Δ = -0.32 mL, p = 0.001). Normalized to intracranial
volume, the reduction remained significant (SEV: Δ =
-0.0003, p = 0.001; ASY: Δ = -0.0001, p = 0.001; CTL:
minimal reduction, Δ ≈ 0, p = 0.005). Minor reductions in
frontal and parietal lobes (e.g., right frontal SEV: Δ =
-1.35 mL, p = 0.001), largely fell within physiological
norms. These mild regional changes are consistent with
expected ageing-related variability and do not suggest
pathological progression. No widespread progressive atrophy
was detected. Conclusions: This study demonstrates delayed,
severity-dependent right hippocampal atrophy in recovered
COVID-19 patients, suggesting long-term vulnerability of
this memory-related region. In contrast, no progression of
atrophy in other areas was observed. These findings
highlight the need for extended post-COVID neurological
monitoring, particularly of hippocampal integrity and its
cognitive relevance.},
keywords = {COVID-19 (Other) / SARS-CoV-2 (Other) / artificial
intelligence (Other) / brain atrophy (Other) / hippocampal
volume (Other) / magnetic resonance imaging (Other)},
cin = {AG Radbruch / AG Heneka},
ddc = {610},
cid = {I:(DE-2719)5000075 / I:(DE-2719)1011303},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41464243},
doi = {10.3390/diagnostics15243244},
url = {https://pub.dzne.de/record/283100},
}